FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4238048772> ?p ?o ?g. }

• W4238048772 abstract "In an effort to improve outcomes of in vitro fertilisation (IVF) cycles the use of growth hormone (GH) has been considered. Most studies investigate the role of GH in normally ovulating infertile women but there is also an interest in the effect of GH on women who respond poorly to ovulation induction and IVF.To assess the effectiveness of GH or growth hormone releasing (GRF) adjuvant therapy, primarily in terms of improving livebirth rate, for women undergoing ovulation induction prior to IVF in (a) patients with no previous history of poor response and (b) patients with a history of poor response.We searched the Cochrane Menstrual Disorders and Subfertility Group's trials register (24 March 2003), the Cochrane Central Register of Controlled Trials (Cochrane Library Issue 1, 2003), MEDLINE (1966 to Feb 2003), EMBASE (1988 to Feb 2003) and Biological Abstracts (1969 to Feb 2003). Reference lists of articles were also searched.All randomised controlled trials were included if they addressed the research question and provided outcome data for intervention and control subjects.Assessment of trial quality and extraction of relevant data was performed independently by two reviewers. Validity was assessed in terms of method of randomisation, completeness of follow-up and co-intervention.Nine studies (401 couples) were included. Three trials concerned patients with no history of poor response to IVF (91 women) and six investigated previous poor responders (302 women). There was no evidence that routine use of GH affected the outcome of livebirth (3 RCTs; OR 1.17, 95% CI 0.38 to 3.59). In women who had previously responded poorly to IVF there was no significant differences in livebirth when combining trials of GH and GRF (4 RCTs; OR 2.42, 95% CI 0.94 to 6.23). However when trials using GH were analysed separately there was an increase in livebirths (3 RCTs; OR 4.37, 95% CI 1.06 to 18.01). There was no significant differences in any adverse events, but these were poorly and inconsistently reported.Although the use of GH in previous poor responders has been found to show a significant improvement in livebirth rate, this result was only just significant. Also, this data is from just three small trials. Therefore, before recommending GH in IVF further research is necessary to fully define its role. Meanwhile GH should only be considered in the context of a clinical trial." @default.
• W4238048772 created "2022-05-12" @default.
• W4238048772 creator A5005201682 @default.
• W4238048772 creator A5014737003 @default.
• W4238048772 creator A5036233784 @default.
• W4238048772 creator A5075997112 @default.
• W4238048772 date "2003-07-21" @default.
• W4238048772 modified "2023-09-26" @default.
• W4238048772 title "Growth hormone for in vitro fertilization" @default.
• W4238048772 cites W1426556480 @default.
• W4238048772 cites W1969769127 @default.
• W4238048772 cites W1980640220 @default.
• W4238048772 cites W1981122333 @default.
• W4238048772 cites W1990760253 @default.
• W4238048772 cites W1999721638 @default.
• W4238048772 cites W2018743939 @default.
• W4238048772 cites W2019414308 @default.
• W4238048772 cites W2029384039 @default.
• W4238048772 cites W2030724156 @default.
• W4238048772 cites W2052249995 @default.
• W4238048772 cites W2057738031 @default.
• W4238048772 cites W2061107904 @default.
• W4238048772 cites W2069579349 @default.
• W4238048772 cites W2087664736 @default.
• W4238048772 cites W2105685705 @default.
• W4238048772 cites W2108372662 @default.
• W4238048772 cites W2117534455 @default.
• W4238048772 cites W2121364435 @default.
• W4238048772 cites W2142504329 @default.
• W4238048772 cites W2163145308 @default.
• W4238048772 cites W2165182326 @default.
• W4238048772 cites W2172144626 @default.
• W4238048772 cites W2260578848 @default.
• W4238048772 cites W2286539257 @default.
• W4238048772 cites W2289147173 @default.
• W4238048772 cites W2298980715 @default.
• W4238048772 cites W2299477891 @default.
• W4238048772 cites W2307916072 @default.
• W4238048772 cites W2344813641 @default.
• W4238048772 cites W2395554930 @default.
• W4238048772 cites W2400261978 @default.
• W4238048772 cites W2406825509 @default.
• W4238048772 cites W2415617117 @default.
• W4238048772 cites W4249135090 @default.
• W4238048772 cites W46795766 @default.
• W4238048772 doi "https://doi.org/10.1002/14651858.cd000099" @default.
• W4238048772 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12917883" @default.
• W4238048772 hasPublicationYear "2003" @default.
• W4238048772 type Work @default.
• W4238048772 citedByCount "25" @default.
• W4238048772 countsByYear W42380487722012 @default.
• W4238048772 countsByYear W42380487722014 @default.
• W4238048772 countsByYear W42380487722015 @default.
• W4238048772 countsByYear W42380487722016 @default.
• W4238048772 countsByYear W42380487722018 @default.
• W4238048772 countsByYear W42380487722019 @default.
• W4238048772 countsByYear W42380487722020 @default.
• W4238048772 countsByYear W42380487722021 @default.
• W4238048772 countsByYear W42380487722022 @default.
• W4238048772 countsByYear W42380487722023 @default.
• W4238048772 crossrefType "reference-entry" @default.
• W4238048772 hasAuthorship W4238048772A5005201682 @default.
• W4238048772 hasAuthorship W4238048772A5014737003 @default.
• W4238048772 hasAuthorship W4238048772A5036233784 @default.
• W4238048772 hasAuthorship W4238048772A5075997112 @default.
• W4238048772 hasConcept C126322002 @default.
• W4238048772 hasConcept C131872663 @default.
• W4238048772 hasConcept C168563851 @default.
• W4238048772 hasConcept C17744445 @default.
• W4238048772 hasConcept C199539241 @default.
• W4238048772 hasConcept C2776478404 @default.
• W4238048772 hasConcept C2777702977 @default.
• W4238048772 hasConcept C2779234561 @default.
• W4238048772 hasConcept C2779473830 @default.
• W4238048772 hasConcept C2781230225 @default.
• W4238048772 hasConcept C29456083 @default.
• W4238048772 hasConcept C512716672 @default.
• W4238048772 hasConcept C54355233 @default.
• W4238048772 hasConcept C71315377 @default.
• W4238048772 hasConcept C71924100 @default.
• W4238048772 hasConcept C86803240 @default.
• W4238048772 hasConcept C95190672 @default.
• W4238048772 hasConceptScore W4238048772C126322002 @default.
• W4238048772 hasConceptScore W4238048772C131872663 @default.
• W4238048772 hasConceptScore W4238048772C168563851 @default.
• W4238048772 hasConceptScore W4238048772C17744445 @default.
• W4238048772 hasConceptScore W4238048772C199539241 @default.
• W4238048772 hasConceptScore W4238048772C2776478404 @default.
• W4238048772 hasConceptScore W4238048772C2777702977 @default.
• W4238048772 hasConceptScore W4238048772C2779234561 @default.
• W4238048772 hasConceptScore W4238048772C2779473830 @default.
• W4238048772 hasConceptScore W4238048772C2781230225 @default.
• W4238048772 hasConceptScore W4238048772C29456083 @default.
• W4238048772 hasConceptScore W4238048772C512716672 @default.
• W4238048772 hasConceptScore W4238048772C54355233 @default.
• W4238048772 hasConceptScore W4238048772C71315377 @default.
• W4238048772 hasConceptScore W4238048772C71924100 @default.
• W4238048772 hasConceptScore W4238048772C86803240 @default.
• W4238048772 hasConceptScore W4238048772C95190672 @default.
• W4238048772 hasLocation W42380487721 @default.

• next